Legal Representation
Attorney
BRUCE W BABER
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 22, 2022 | MAB3 | E | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
| Jun 28, 2022 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
| Jun 28, 2022 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| May 19, 2022 | EXFB | T | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | Loading... |
| Sep 10, 2021 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Sep 10, 2021 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Mar 10, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 10, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 10, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 17, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 16, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 16, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 14, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 12, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 29, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 28, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 18, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Therapeutic medicines, compounds and preparations created using molecular, protein and antibody conjugation and modification technologies; Conjugation-ready kits including assays, reagents, nucleic acids and enzymes, and assay materials used for research purposes
Class 042
Research and development services for others in the fields of nucleic acid, protein and antibody conjugation and modification; Development of therapeutic medicines, compounds and preparations for others
Additional Information
Design Mark
The mark consists of The mark consists of the word BRICKBIO appearing to the right of a design element comprised of two interlocking squares oriented vertically. No claim is made to the placement of the design element in relationship to the word BRICKBIO.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042